Dr. Jeanne Loring
The National Stem Cell Foundation (NSCF) today announced that Dr. Jeanne Loring, an internationally recognized authority in the field of stem cells, neurobiology and genomics, will be joining NSCF as Senior Scientific Advisor.
Dr. Loring is Professor Emeritus at The Scripps Research Institute, where she was founding Director of the Center for Regenerative Medicine. Dr. Loring holds five patents on stem cells and genomics and has authored three books and more than 200 publications in scientific journals. She has founded two stem-cell based companies, Arcos Bioscience (now part of Viacyte) and Aspen Neuroscience, a biotechnology company founded in 2018 to continue development of a neuron replacement therapy for Parkinson’s disease.
Dr. Loring is the recipient of multiple awards for her accomplishments as a scientist, educator and advocate for evidence-based patient therapies. She serves on bioethics and scientific advisory boards in addition to the editorial boards of several scientific journals and advises governmental and private granting agencies in several countries. Through her laboratory courses, she has trained more than 400 scientists in stem cell technologies.
In addition to her work on Parkinson’s disease, Dr. Loring investigates stem cell-based therapies for multiple sclerosis and autism and is part of an NSCF-funded collaboration conducting the first study of neurodegeneration on the International Space Station. She also works with the San Diego Zoo Institute for Conservation Research, using stem cell technology in an effort to rescue the Northern white rhinoceros from extinction. She has a B.S. in Molecular Biology from the University of Washington and a Ph.D. in Developmental Neurobiology from the Institute for Molecular Biology at the University of Oregon.
“I’m delighted to welcome Dr. Loring to NSCF as Senior Scientific Advisor. It’s been a great honor and pleasure to work with Jeanne over the last several years, and her extensive experience in so many areas will be invaluable to us moving forward,” said Dr. Paula Grisanti, CEO of the National Stem Cell Foundation.
“NSCF is fortunate to have this opportunity to build on our relationship with Dr. Loring,” said NSCF Board Chair Bruce Wolff. “Her role as Senior Scientific Advisor will help advance our commitment to funding research that may change thinking in a field of study for patients in need of new therapeutic options for diseases that affect us all.”